References:
- Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et
al. Heart Disease and Stroke Statistics-2016 Update: A Report From the
American Heart Association. Circulation. 2016;133:e38-360
- Chugh
SS, Havmoeller
R, Narayanan
K, Singh
D, Rienstra
M, Benjamin
EJ, et al. Worldwide epidemiology of atrial fibrillation: a Global
Burden of Disease 2010 Study. Circulation. 2014;129:837-47
- Saposnik G, Gladstone D, Raptis R, Hart RG. Atrial fibrillation in
ischemic stroke: predicting response to thrombolysis and clinical
outcomes. Stroke. 2013;44:99–104
- Seet RC, Zhang Y, Wijdicks EF, Rabinstein AA. Relationship between
chronic atrial fibrillation and worse outcomes in stroke patients
after intravenous thrombolysis. Arch Neurol. 2011;68:1454–1458
- Alkhouli
M, Noseworthy
PA, Rihal
CS, Holmes
DR Jr. Stroke Prevention in Nonvalvular Atrial Fibrillation: A
Stakeholder Perspective. J Am Coll Cardiol. 2018;71:2790-2801
- Hayden
DT, Hannon
N, Callaly E, Ní Chróinín
D, Horgan
G, Kyne L, et al. Rates and Determinants of 5-Year Outcomes After
Atrial Fibrillation-Related Stroke: A Population Study. Stroke.
2015;46:3488-93
- Oldgren
J, Healey
JS, Ezekowitz M, Commerford P, Avezum A, Pais P, et al. Variations in
cause and management of atrial fibrillation in a prospective registry
of 15,400 emergency department patients in 46 countries: the RE-LY
Atrial Fibrillation Registry. Circulation. 2014;129:1568-76
- Hsu
JC, Maddox
TM, Kennedy
KF, Katz
DF, Marzec
LN, Lubitz
SA, et al. Oral Anticoagulant Therapy Prescription in Patients With
Atrial Fibrillation Across the Spectrum of Stroke Risk: Insights From
the NCDR PINNACLE Registry. JAMA Cardiol. 2016;1:55-62
- Holmes
DR Jr, Alkhouli
M, Reddy
V. Left Atrial Appendage Occlusion for The Unmet Clinical Needs of
Stroke Prevention in Nonvalvular Atrial Fibrillation. Mayo Clin Proc.
2019;94:864-874
- Holmes
DR, Reddy
VY, Turi
ZG, Doshi
SK, Sievert
H, Buchbinder
M, et al. Percutaneous closure of the left atrial appendage versus
warfarin therapy for prevention of stroke in patients with atrial
fibrillation: a randomised non-inferiority trial. Lancet.
2009;374:534-42
- Holmes
DR
Jr, Kar
S, Price
MJ, Whisenant
B, Sievert
H, Doshi
SK, et al. Prospective randomized evaluation of the Watchman Left
Atrial Appendage Closure device in patients with atrial fibrillation
versus long-term warfarin therapy: the PREVAIL trial. J Am Coll
Cardiol. 2014;64:1-12
- Agency for Healthcare Research and Quality. Overview of the national
inpatient sample (NIS). Rockville: AHRQ.
https://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed on
January 21, 2020
- Vuddanda
VLK, Turagam MK, Umale
NA, Shah
Z, Lakkireddy DR, Bartus K, et al. Incidence and causes of
in-hospital outcomes and 30-day readmissions after percutaneous left
atrial appendage closure: A US nationwide retrospective cohort study
using claims data. Heart Rhythm. 2019 Sep 17
- January
CT, Wann
LS, Calkins
H, Chen
LY, Cigarroa
JE, Cleveland
JC Jr, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS
guideline for the management of patients with atrial fibrillation: A
Report of the American College of Cardiology/American Heart
Association Task Force on Clinical Practice Guidelines and the Heart
Rhythm Society. Heart Rhythm. 2019;16:e66-e93
- Holmes
DR
Jr, Reddy
VY, Gordon
NT, Delurgio
D, Doshi
SK, Desai
AJ, et al. Long-Term Safety and Efficacy in Continued Access Left
Atrial Appendage Closure Registries. J Am Coll Cardiol.
2019;74:2878-2889
- Boersma
LV, Schmidt
B, Betts
TR, Sievert
H, Tamburino
C, Teiger
E, et al. Implant success and safety of left atrial appendage closure
with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION
registry. Eur Heart J. 2016;37:2465-74
- Reddy
VY, Gibson
DN, Kar S, O’Neill
W, Doshi
SK, Horton
RP, et al. Post-Approval U.S. Experience With Left Atrial Appendage
Closure for Stroke Prevention in Atrial Fibrillation. J Am Coll
Cardiol. 2017;69:253-261
- Freeman
JV, Varosy
P, Price
MJ, Slotwiner D, Kusumoto FM, Rammohan C, Kavinsky
CJ, Turi
ZG, Akar J, Koutras
C, Curtis
JP, Masoudi FA. The NCDR Left Atrial Appendage Occlusion Registry.
J Am Coll
Cardiol. 2020;75:1503-1518
- Centers for Medicare and Medicaid Services Coverage with Evidence
Development (Left Atrial Appendage Occlusion).
https://www.cms.gov/Medicare/Coverage/Coverage-with-Evidence-
Development/LAAC. Accessed on March 16, 2020